Rheumatology Drugs Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Disease Modifying Anti-rheumatic Drugs
1.2.3 Nonsteroidal Anti-inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Uric Acid Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rheumatology Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rheumatology Drugs Market Perspective (2017-2028)
2.2 Rheumatology Drugs Growth Trends by Region
2.2.1 Rheumatology Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rheumatology Drugs Historic Market Size by Region (2017-2022)
2.2.3 Rheumatology Drugs Forecasted Market Size by Region (2023-2028)
2.3 Rheumatology Drugs Market Dynamics
2.3.1 Rheumatology Drugs Industry Trends
2.3.2 Rheumatology Drugs Market Drivers
2.3.3 Rheumatology Drugs Market Challenges
2.3.4 Rheumatology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatology Drugs Players by Revenue
3.1.1 Global Top Rheumatology Drugs Players by Revenue (2017-2022)
3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatology Drugs Revenue
3.4 Global Rheumatology Drugs Market Concentration Ratio
3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2021
3.5 Rheumatology Drugs Key Players Head office and Area Served
3.6 Key Players Rheumatology Drugs Product Solution and Service
3.7 Date of Enter into Rheumatology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatology Drugs Breakdown Data by Type
4.1 Global Rheumatology Drugs Historic Market Size by Type (2017-2022)
4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2023-2028)
5 Rheumatology Drugs Breakdown Data by Application
5.1 Global Rheumatology Drugs Historic Market Size by Application (2017-2022)
5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rheumatology Drugs Market Size (2017-2028)
6.2 North America Rheumatology Drugs Market Size by Country (2017-2022)
6.3 North America Rheumatology Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Rheumatology Drugs Market Size (2017-2028)
7.2 Europe Rheumatology Drugs Market Size by Country (2017-2022)
7.3 Europe Rheumatology Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatology Drugs Market Size (2017-2028)
8.2 Asia-Pacific Rheumatology Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Rheumatology Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Rheumatology Drugs Market Size (2017-2028)
9.2 Latin America Rheumatology Drugs Market Size by Country (2017-2022)
9.3 Latin America Rheumatology Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatology Drugs Market Size (2017-2028)
10.2 Middle East & Africa Rheumatology Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Rheumatology Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2017-2022)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rheumatology Drugs Introduction
11.2.4 Sanofi Revenue in Rheumatology Drugs Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Genentech
11.3.1 Genentech Company Detail
11.3.2 Genentech Business Overview
11.3.3 Genentech Rheumatology Drugs Introduction
11.3.4 Genentech Revenue in Rheumatology Drugs Business (2017-2022)
11.3.5 Genentech Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Rheumatology Drugs Introduction
11.4.4 Novartis Revenue in Rheumatology Drugs Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Rheumatology Drugs Introduction
11.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2017-2022)
11.5.5 Janssen Biotech Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Rheumatology Drugs Introduction
11.6.4 Amgen Revenue in Rheumatology Drugs Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Rheumatology Drugs Introduction
11.7.4 AbbVie Revenue in Rheumatology Drugs Business (2017-2022)
11.7.5 AbbVie Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Rheumatology Drugs Introduction
11.8.4 Pfizer Revenue in Rheumatology Drugs Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Detail
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2017-2022)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Detail
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Rheumatology Drugs Introduction
11.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2017-2022)
11.10.5 Merck & Co. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Rheumatology Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs
Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Uric Acid Drugs
Table 6. Key Players of Others
Table 7. Global Rheumatology Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Rheumatology Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Rheumatology Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Rheumatology Drugs Market Share by Region (2017-2022)
Table 11. Global Rheumatology Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Rheumatology Drugs Market Share by Region (2023-2028)
Table 13. Rheumatology Drugs Market Trends
Table 14. Rheumatology Drugs Market Drivers
Table 15. Rheumatology Drugs Market Challenges
Table 16. Rheumatology Drugs Market Restraints
Table 17. Global Rheumatology Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Rheumatology Drugs Market Share by Players (2017-2022)
Table 19. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2021)
Table 20. Ranking of Global Top Rheumatology Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Rheumatology Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Rheumatology Drugs Product Solution and Service
Table 24. Date of Enter into Rheumatology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rheumatology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Rheumatology Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Rheumatology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Rheumatology Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Rheumatology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Rheumatology Drugs Revenue Market Share by Application (2017-2022)
Table 32. Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Rheumatology Drugs Revenue Market Share by Application (2023-2028)
Table 34. North America Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Rheumatology Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Rheumatology Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Takeda Pharmaceutical Company Detail
Table 45. Takeda Pharmaceutical Business Overview
Table 46. Takeda Pharmaceutical Rheumatology Drugs Product
Table 47. Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 48. Takeda Pharmaceutical Recent Development
Table 49. Sanofi Company Detail
Table 50. Sanofi Business Overview
Table 51. Sanofi Rheumatology Drugs Product
Table 52. Sanofi Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 53. Sanofi Recent Development
Table 54. Genentech Company Detail
Table 55. Genentech Business Overview
Table 56. Genentech Rheumatology Drugs Product
Table 57. Genentech Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 58. Genentech Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Rheumatology Drugs Product
Table 62. Novartis Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Janssen Biotech Company Detail
Table 65. Janssen Biotech Business Overview
Table 66. Janssen Biotech Rheumatology Drugs Product
Table 67. Janssen Biotech Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 68. Janssen Biotech Recent Development
Table 69. Amgen Company Detail
Table 70. Amgen Business Overview
Table 71. Amgen Rheumatology Drugs Product
Table 72. Amgen Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. AbbVie Company Detail
Table 75. AbbVie Business Overview
Table 76. AbbVie Rheumatology Drugs Product
Table 77. AbbVie Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Pfizer Company Detail
Table 80. Pfizer Business Overview
Table 81. Pfizer Rheumatology Drugs Product
Table 82. Pfizer Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Bristol-Myers Squibb Company Company Detail
Table 85. Bristol-Myers Squibb Company Business Overview
Table 86. Bristol-Myers Squibb Company Rheumatology Drugs Product
Table 87. Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 88. Bristol-Myers Squibb Company Recent Development
Table 89. Merck & Co. Company Detail
Table 90. Merck & Co. Business Overview
Table 91. Merck & Co. Rheumatology Drugs Product
Table 92. Merck & Co. Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
Table 93. Merck & Co. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatology Drugs Market Share by Type: 2021 VS 2028
Figure 2. Disease Modifying Anti-rheumatic Drugs Features
Figure 3. Nonsteroidal Anti-inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Uric Acid Drugs Features
Figure 6. Others Features
Figure 7. Global Rheumatology Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Rheumatology Drugs Report Years Considered
Figure 12. Global Rheumatology Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Rheumatology Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Rheumatology Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global Rheumatology Drugs Market Share by Players in 2021
Figure 16. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Rheumatology Drugs Revenue in 2021
Figure 18. North America Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Rheumatology Drugs Market Share by Country (2017-2028)
Figure 20. United States Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Rheumatology Drugs Market Share by Country (2017-2028)
Figure 24. Germany Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Rheumatology Drugs Market Share by Region (2017-2028)
Figure 32. China Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Rheumatology Drugs Market Share by Country (2017-2028)
Figure 40. Mexico Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Rheumatology Drugs Market Share by Country (2017-2028)
Figure 44. Turkey Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 47. Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 48. Genentech Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 49. Novartis Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 50. Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 51. Amgen Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 52. AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 53. Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 54. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 55. Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Industry Market Size
